Stocks TelegraphStocks Telegraph
Stock Ideas

ENSC Financial Statements and Analysis

NASDAQ : ENSC

Ensysce Biosciences

$0.61
0.0626+11.44%
At Close 4:00 PM
68.03
BESG ScoreESG Rating

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateSep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20252025202520242024
periodQ3Q2Q1Q3Q2
revenue493.104K1.371M1.32M0181.797K
cost of revenue2.955M1.923M00947.229K
gross profit-2.462M-551.992K1.32M0-765.432K
gross profit ratio-4.992-0.4021.000-4.21
research and development expenses2.955M1.923M1.886M1.691M947.229K
general and administrative expenses1.279M1.199M1.402M1.083M1.19M
selling and marketing expenses00000
selling general and administrative expenses1.279M1.199M1.402M1.083M1.19M
other expenses-2.955M-1.923M-716.0000
operating expenses1.279M1.199M3.287M2.774M2.137M
cost and expenses4.234M3.122M3.287M-644.746K2.137M
interest income00000
interest expense6.369K3.16K3.856K4.063K27.563K
depreciation and amortization3.741M1.751M021.083K0
ebitda18.336K0-1.942M665.829K-1.94M
ebitda ratio0.0370-1.4710-10.756
operating income-3.741M-1.751M-1.968M644.746K-1.955M
operating income ratio-7.587-1.276-1.4910-10.756
total other income expenses net11.967K16.998K21.939K17.023K-12.351K
income before tax-3.729M-1.734M-1.946M661.769K-1.968M
income before tax ratio-7.563-1.264-1.4740-10.824
income tax expense00000
net income-3.729M-1.733M-1.946M661.769K-1.968M
net income ratio-7.563-1.264-1.4740-10.824
eps-1.29-0.79-1.390.067-0.22
eps diluted-1.29-0.79-1.390.067-0.22
weighted average shs out2.886M2.202M1.401M9.89M8.817M
weighted average shs out dil2.886M2.202M1.401M9.89M8.817M
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateSep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20252025202520242024
periodQ3Q2Q1Q3Q2
cash and cash equivalents1.673M2.212M3.052M4.154M1.043M
short term investments00000
cash and short term investments1.673M2.212M3.052M4.154M1.043M
net receivables4.411K1.205M22.00K1.783M224.223K
inventory00000
other current assets1.251M1.865M1.327M3.154M1.192M
total current assets2.928M5.282M4.401M9.091M2.46M
property plant equipment net123.643K0000
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets127.55K292.86K210.883K294.217K335.883K
total non current assets251.193K292.86K210.883K294.217K335.883K
other assets00000
total assets3.179M5.574M4.612M9.385M2.796M
account payables463.458K1.043M615.295K1.968M481.971K
short term debt364.066K424.521K257.383K387.176K454.463K
tax payables00000
deferred revenue00000
other current liabilities1.477M1.046M888.498K447.035K370.186K
total current liabilities2.305M2.513M1.761M2.802M1.307M
long term debt00000
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities35.001.033K130.18K3.213K9.615K
total non current liabilities35.001.033K130.18K3.213K9.615K
other liabilities00000
capital lease obligations00000
total liabilities2.305M2.514M1.891M2.805M1.316M
preferred stock00000
common stock320.00241.00165.001.387K815.00
retained earnings-136.952M-133.223M-131.49M-125.98M-126.642M
accumulated other comprehensive income loss00000
other total stockholders equity138.155M136.612M134.539M132.887M128.449M
total stockholders equity1.203M3.389M3.049M6.908M1.808M
total equity874.714K3.06M2.721M6.58M1.479M
total liabilities and stockholders equity3.179M5.574M4.612M9.385M2.796M
minority interest-328.649K-328.649K-328.483K-328.483K-328.483K
total investments00000
total debt364.066K424.521K257.383K387.176K454.463K
net debt-1.309M-1.787M-2.795M-3.766M-588.768K
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateSep 30, 2025Jun 30, 2025Mar 31, 2025Jun 30, 2024Mar 31, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20252025202520242024
periodQ3Q2Q1Q2Q1
deferred income tax00000
stock based compensation96.576K156.921K46.093K26.549K33.207K
change in working capital2.344M-1.225M182.786K-388.394K-1.515M
accounts receivables1.201M-1.183M102.113K-127.999K1.337K
inventory00000
accounts payables0427.537K-741.784K-499.749K-1.296M
other working capital1.143M-469.483K822.457K239.354K-220.522K
other non cash items-577.212K94.651K9.282K674.044K2.517M
net cash provided by operating activities-1.866M-2.707M-1.707M-2.31M-3.408M
investments in property plant and equipment-123.643K0000
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites-123.643K0000
debt repayment-39.979K-24.067K-47.225K-51.227K-485.19K
common stock issued02.243M1.448M06.794M
common stock repurchased00000
dividends paid0000-290.00
other financing activites1.491M-352.854K-142.949K-51.227K-619.176K
net cash used provided by financing activities1.451M1.866M1.258M-51.227K5.689M
effect of forex changes on cash00000
net change in cash-538.357K-840.916K-449.586K-2.361M2.281M
cash at end of period1.673M2.212M3.052M1.043M3.404M
cash at beginning of period2.212M3.052M3.502M3.404M1.124M
operating cashflow-1.866M-2.707M-1.707M-2.31M-3.408M
capital expenditure-123.643K0000
free cash flow-1.99M-2.707M-1.707M-2.31M-3.408M
Graph

Frequently Asked Questions

How did Ensysce Biosciences, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ENSC generated $493.10K in revenue last quarter, while its costs came in at $2.95M.
Last quarter, how much Gross Profit did Ensysce Biosciences, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Ensysce Biosciences, Inc. reported a -$2.46M Gross Profit for the quarter ended Sep 30, 2025.
Have ENSC's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ENSC incurred $1.28M worth of Operating Expenses, while it generated -$3.74M worth of Operating Income.
How much Net Income has ENSC posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Ensysce Biosciences, Inc., the company generated -$3.73M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Ensysce Biosciences, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Ensysce Biosciences, Inc. as of the end of the last quarter was $1.67M.
What are ENSC's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ENSC had Total Net Receivables of $4.41K.
In terms of Total Assets and Current Assets, where did Ensysce Biosciences, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ENSC were $2.93M, while the Total Assets stand at $3.18M.
As of the last quarter, how much Total Debt did Ensysce Biosciences, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ENSC's debt was $364.07K at the end of the last quarter.
What were ENSC's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ENSC reported total liabilities of $2.30M.
How much did ENSC's Working Capital change over the last quarter?
Working Capital Change for ENSC was $2.34M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
ENSC generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ENSC generated -$1.87M of Cash from Operating Activities during its recently reported quarter.
What was ENSC's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ENSC reported a -$538.36K Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph